862 related articles for article (PubMed ID: 11390617)
1. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
Latham T; Galarza JM
J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
[TBL] [Abstract][Full Text] [Related]
2. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
3. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
Galarza JM; Latham T; Cupo A
Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
[TBL] [Abstract][Full Text] [Related]
4. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
Pushko P; Tumpey TM; Bu F; Knell J; Robinson R; Smith G
Vaccine; 2005 Dec; 23(50):5751-9. PubMed ID: 16143432
[TBL] [Abstract][Full Text] [Related]
5. Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology.
Chlanda P; Schraidt O; Kummer S; Riches J; Oberwinkler H; Prinz S; Kräusslich HG; Briggs JA
J Virol; 2015 Sep; 89(17):8957-66. PubMed ID: 26085153
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC
Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.
Chen BJ; Leser GP; Morita E; Lamb RA
J Virol; 2007 Jul; 81(13):7111-23. PubMed ID: 17475660
[TBL] [Abstract][Full Text] [Related]
8. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity.
Zhao W; Liao GY; Jiang YJ; Jiang SD
Chin Med J (Engl); 2004 Aug; 117(8):1217-22. PubMed ID: 15361298
[TBL] [Abstract][Full Text] [Related]
9. Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase.
Lai JC; Chan WW; Kien F; Nicholls JM; Peiris JS; Garcia JM
J Gen Virol; 2010 Sep; 91(Pt 9):2322-30. PubMed ID: 20505010
[TBL] [Abstract][Full Text] [Related]
10. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
[TBL] [Abstract][Full Text] [Related]
11. Membrane-anchored incorporation of a foreign protein in recombinant influenza virions.
Zhou Y; König M; Hobom G; Neumeier E
Virology; 1998 Jun; 246(1):83-94. PubMed ID: 9656996
[TBL] [Abstract][Full Text] [Related]
12. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks.
Prel A; Le Gall-Reculé G; Jestin V
Avian Pathol; 2008 Oct; 37(5):513-20. PubMed ID: 18798027
[TBL] [Abstract][Full Text] [Related]
13. A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein.
Muraki Y; Murata T; Takashita E; Matsuzaki Y; Sugawara K; Hongo S
J Virol; 2007 Aug; 81(16):8766-73. PubMed ID: 17537859
[TBL] [Abstract][Full Text] [Related]
14. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
[TBL] [Abstract][Full Text] [Related]
15. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
Roberts PC; Lamb RA; Compans RW
Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
[TBL] [Abstract][Full Text] [Related]
17. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein.
Sugahara F; Uchiyama T; Watanabe H; Shimazu Y; Kuwayama M; Fujii Y; Kiyotani K; Adachi A; Kohno N; Yoshida T; Sakaguchi T
Virology; 2004 Jul; 325(1):1-10. PubMed ID: 15231380
[TBL] [Abstract][Full Text] [Related]
18. Bovine leukemia virus Gag particle assembly in insect cells: formation of chimeric particles by domain-switched leukemia/lentivirus Gag polyprotein.
Kakker NK; Mikhailov MV; Nermut MV; Burny A; Roy P
Virology; 1999 Dec; 265(2):308-18. PubMed ID: 10600602
[TBL] [Abstract][Full Text] [Related]
19. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.
Haynes JR; Dokken L; Wiley JA; Cawthon AG; Bigger J; Harmsen AG; Richardson C
Vaccine; 2009 Jan; 27(4):530-41. PubMed ID: 19026705
[TBL] [Abstract][Full Text] [Related]
20. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
